Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Status
- RECRUITING
- Phase
- PHASE3
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
- Status
- COMPLETED
- Phase
- N/A
Hippocampus-Avoidance Whole-Brain Radiation Therapy With Simultaneous Integrated Boost for BMs of NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases
- Status
- RECRUITING
- Phase
- PHASE2
Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
- Status
- RECRUITING
- Phase
- N/A
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
- Status
- WITHDRAWN
- Phase
- PHASE2
First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size
- Status
- COMPLETED
- Phase
- N/A
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
- Status
- RECRUITING
- Phase
- PHASE2
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A